Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Valsartan treatment reverses erectile dysfunction in diabetic rats

Abstract

In order to investigate the effect of angiotensin receptor blockage (ARB) for the treatment on diabetic erectile dysfunction (ED), we used male Sprague–Dawley rats injected with 65 mg/kg streptozotocin to induce diabetes mellitus. The diabetic rats with ED were selected by hypodermic injection of apomorphine (APO) after 8 weeks of model setting. All rats were divided into four groups: G1 (normal control rats), G2 (diabetic rats treated with normal saline), G3 (diabetic rats treated with valsartan) and G4 (diabetic rats treated with spironolactone). After treatment with drugs for 8 weeks, the rate of erection for each group was evaluated after the injection of APO. The intracavernous pressure (ICP) of each rat was then recorded before and after the electrostimulation of the major pelvic ganglion. The rates of erection and the ICP after electrostimulation for diabetic rats treated with valsartan were significantly higher than that in diabetic rats treated with normal saline and spironolactone. The ARB may be an effective therapy for diabetics with ED.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB . Impotence and its medical and psychosocial correlates: results of the Massachusettes Male Ageing Study. J Urol 1994; 151: 54–61.

    Article  CAS  Google Scholar 

  2. Salama N, Kagawa S . Ultra structural changes in collagen of penile tunica albuginea in aged and diabetic rats. Int J Impot Res 1999; 11: 99–105.

    Article  CAS  Google Scholar 

  3. Johnston CI . Biochemistry and pharmacology of the renin–angiotensin system. Drugs 1990; 39: 21–31.

    Article  CAS  Google Scholar 

  4. Park JK, Kim SZ, Kim SH, Kim YG, Cho KW . Renin–angiotensin system in rabbit corpus cavernosum: functional characterization of angiotensin II receptors. J Urol 1997; 158: 653–658.

    Article  CAS  Google Scholar 

  5. Park JK, Kim SZ, Kim SH, Park YK, Cho KW . Renin angiotensin system of rabbit clitoral cavernosum: interaction with nitric oxide. J Urol 2000; 164: 556–561.

    Article  CAS  Google Scholar 

  6. Hale Tm, Okabe H, Heaton JP, Adams MA . Antihypertensive drugs induce structural remodeling of the penile vasculature. J Urol 2001; 160: 739–745.

    Article  Google Scholar 

  7. Li SX, Dai YT . Effects of Angiotensinα on male rats with diabetic erectile dysfunction. Zhonghua Nan Ke Xue 2005; 11: 346–349.

    CAS  PubMed  Google Scholar 

  8. Heaton JP, Varrin SJ, Morales A . The characterization of a bioassay of erectile function in a rat model. J Urol 1991; 145: 1099–1102.

    Article  CAS  Google Scholar 

  9. Von Lutterotti N, Catanzaro D, Sealey JE, Laragh JH . Renin is not synthesized by cardiac and extra renal vascular tissues: review of experimental evidence. Circulation 1994; 89: 458–470.

    Article  CAS  Google Scholar 

  10. Santis WF, Peters CA, Yalla SV, Sullivan MP . Ureteral function is modulated by a local renin–angiotensin system. J Urol 2003; 170: 259–263.

    Article  CAS  Google Scholar 

  11. Dinh DT, Frauman AG, Somers GR, Ohishi M, Zhou J, Casley DJ et al. Evidence for activation of the renin–angiotensin system in the human prostate: increased angiotensin II and reduced AT(1) receptor expression in benign prostatic hyperplasia. J Pathol 2002; 196: 213–219.

    Article  CAS  Google Scholar 

  12. Kifor I, Williams GH, Vickers MA, Sullivan MP, Jodbert P, Dluhy RG . Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum. J Urol 1997; 157: 1920–1925.

    Article  CAS  Google Scholar 

  13. Becker AJ, Ckert SU, Stief CG, Scheller F, Knapp WH, Hartmann U et al. Plasma levels of angiotensin II during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction. Urology 2001; 58: 805–810.

    Article  CAS  Google Scholar 

  14. EL Melegy NT, Ali ME, Awad EM . Plasma levels of endothelin-1, angiotensin II, nitric oxide and prostaglandin E in the venous and cavernosal blood of patients with erectile dysfunction. BJU Int 2005; 96: 1079–1086.

    Article  CAS  Google Scholar 

  15. Dorrance AM, Lewis RW, Mills TM . Captopril treatment reverses erectile dysfunction in male stroke prone spontaneously hypertensive rats. Int J Impot Res 2002; 14: 494–497.

    Article  CAS  Google Scholar 

  16. Toblli JE, Stella I, Mazza ON, Ferder L, Inserra F . Different effect of Losartan and amlodipine on penile structures in male spontaneously hypertensive rats. Am J Nephrol 2004; 24: 614–623.

    Article  CAS  Google Scholar 

  17. Chan P, Liu JC, Tong YC, Chen YJ, Wang CC, Tomlinson B et al. Effects of Losartan on the sexual behavior of male rats. Pharmacology 1999; 58: 132–139.

    Article  CAS  Google Scholar 

  18. Park K, Shin JW, Oh JK, Ryu KS, Kim SW, Paick JS . Restoration of erectile capacity in normotensive aged rats by modulation of angiotensin receptor type 1. J Androl 2005; 26: 123–128.

    CAS  PubMed  Google Scholar 

  19. Llisterri JL, Lozano Vidal JV, Aznar Vicente J, Argaya Roca M, Pol Bravo C, Sanchez Zamorano MA et al. Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci 2001; 321: 336–341.

    Article  CAS  Google Scholar 

  20. Toblli JE, Stella I, Mazza ON, Ferder L, Inserra F . Candesartan cilexetil protects cavernous tissue in spontaneously hypertensive rats. Int J Impot Res 2004; 16: 305–312.

    Article  CAS  Google Scholar 

  21. Moore CR, Wang R . Pathophysiology and treatment of diabetic erectile dysfunction. Asian J Androl 2006; 8: 675–684.

    Article  Google Scholar 

  22. Comiter CV, Sullivan MP, Yalla SV, Kifor I . Effect of angiotensin II on corpus cavernosum smooth muscle in relation to nitric oxide environment: in vitro studies in canines. Int J Impot Res 1997; 9: 135–140.

    Article  CAS  Google Scholar 

  23. Park JK, Kim SZ, Kim JU, Kim YG, Kim SM, Cho KW . Comparison of effects of angiotensin peptides in the regulation of clitoral cavernosum smooth muscle tone. Int J Impot Res 2002; 14: 72–80.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank D Stradinger for her editing assistance.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to R Wang or Y T Dai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, Y., Li, S., Yao, L. et al. Valsartan treatment reverses erectile dysfunction in diabetic rats. Int J Impot Res 19, 366–370 (2007). https://doi.org/10.1038/sj.ijir.3901534

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901534

Keywords

This article is cited by

Search

Quick links